PharmaShots | Incisive News in 3 Shots

Subscribe Now

Severe Aplastic Anemia

Novartis' Promacta Receives FDA's Breakthrough Therapy Designation for Severe Aplastic Anemia (SAA)

Novartis' Promacta Receives FDA's Breakthrough Therapy Designation for Severe Aplastic Anemia (SAA)

January 4, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us